The Structure and Biological Features of Fibrinogen and Fibrin
暂无分享,去创建一个
[1] K. Kaplan,et al. The binding of thrombin by fibrin. , 1979, The Journal of biological chemistry.
[2] J. Hainfeld,et al. Identification and mass analysis of human fibrinogen molecules and their domains by scanning transmission electron microscopy. , 1981, Journal of molecular biology.
[3] W. Brandt,et al. Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at cross-linked sites of the gamma-chain. Sequence of carboxy-terminal cyanogen bromide gamma-chain fragments. , 1987, Biochemistry.
[4] T. Tamaki,et al. Cross-linking of α2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor , 1981 .
[5] J. Gris,et al. Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism. , 1993, The Journal of laboratory and clinical medicine.
[6] D. Cheresh,et al. Distinct biological consequences of integrin alpha v beta 3-mediated melanoma cell adhesion to fibrinogen and its plasmic fragments. , 1992, The Journal of biological chemistry.
[7] G. Smejkal,et al. Isolation and Characterization of the Fibrin Intermediate Arising from Cleavage of One Fibrinopeptide A from Fibrinogen* , 1996, The Journal of Biological Chemistry.
[8] D. Collen. On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.
[9] D. B. Smith,et al. Quantitative measurement of plasma gelsolin and its incorporation into fibrin clots. , 1987, The Journal of laboratory and clinical medicine.
[10] J. Finlayson,et al. Human fibrinogen heterogeneities. 3. Identification of chain variants. , 1972, The Journal of biological chemistry.
[11] R. Hill,et al. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. , 1970, Proceedings of the National Academy of Sciences of the United States of America.
[12] K. Siebenlist,et al. Protransglutaminase (Factor XIII) Mediated Crosslinking of Fibrinogen and Fibrin* , 2001, Thrombosis and Haemostasis.
[13] D. Mosher. Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. , 1975, The Journal of biological chemistry.
[14] S. Kimura,et al. Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor. , 1986, The Journal of biological chemistry.
[15] W. Nieuwenhuizen,et al. Evaluation of the factors contributing to fibrin-dependent plasminogen activation. , 1998, Thrombosis and haemostasis.
[16] S. Thorsen,et al. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. , 1984, European journal of biochemistry.
[17] L. Lorand,et al. The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] G. Vilaire,et al. Exposure of platelet fibrinogen receptors by ADP and epinephrine. , 1979, The Journal of clinical investigation.
[19] J. Hainfeld,et al. The location of the carboxy-terminal region of chains in fibrinogen and fibrin D domains , 1998 .
[20] C. Francis,et al. Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42. , 1993, Blood.
[21] C. Francis,et al. Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain. , 1989, The Journal of clinical investigation.
[22] J. Hainfeld,et al. Orientation of the Carboxy-terminal Regions of Fibrin γ Chain Dimers Determined from the Crosslinked Products Formed in Mixtures of Fibrin, Fragment D, and Factor XIIIa , 1995, Thrombosis and Haemostasis.
[23] M. Mosesson,et al. Cross-linking of Plasminogen Activator Inhibitor 2 and α2-Antiplasmin to Fibrin(ogen)* , 2000, The Journal of Biological Chemistry.
[24] M. Rånby,et al. Studies on the kinetics of plasminogen activation by tissue plasminogen activator. , 1982, Biochimica et biophysica acta.
[25] R. Williams,et al. MORPHOLOGY OF FIBRINOGEN MONOMERS AND OF FIBRIN PROTOFIBRILS * , 1983, Annals of the New York Academy of Sciences.
[26] W. Nieuwenhuizen,et al. The sequence gamma-(312-324) is a fibrin-specific epitope. , 1991, Blood.
[27] K. Siebenlist,et al. Factors affecting γ-chain multimer formation in cross-linked fibrin , 1992 .
[28] G. Müller‐Berghaus,et al. Crosslinking of fibrinogen to immobilized DesAA-fibrin. , 1985, Thrombosis research.
[29] Tami L. Bach,et al. Endothelial Cell VE-cadherin Functions as a Receptor for the β15–42 Sequence of Fibrin* , 1998, The Journal of Biological Chemistry.
[30] J. Hainfeld,et al. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys). , 1995, The Journal of clinical investigation.
[31] S. Timmons,et al. Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain. , 1984, Biochemistry.
[32] T. Odrljin,et al. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain. , 1996, Blood.
[33] C. Southan,et al. COVALENT STRUCTURE OF FIBRINOGEN , 1983, Annals of the New York Academy of Sciences.
[34] R. Exley,et al. Monocyte Plasminogen Activator Inhibitor 2 (PAI-2) Inhibits u-PA-mediated Fibrin Clot Lysis and Is Cross-linked to Fibrin , 1999, Thrombosis and Haemostasis.
[35] M. Mosesson,et al. Interactions Among Heparin, Cold-Insoluble Globulin, and Fibrinogen in Formation of the Heparin Precipitable Fraction of Plasma , 1977, Thrombosis and Haemostasis.
[36] J. Hermans,et al. Structure of the fibrin protofibril. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[37] P. Harpel,et al. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I. , 1985, The Journal of biological chemistry.
[38] J. Weisel,et al. Role of the alpha C domains of fibrin in clot formation. , 1994, Biochemistry.
[39] E. Davie,et al. gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing. , 1984, Biochemistry.
[40] B. Blombäck,et al. A two-step fibrinogen–fibrin transition in blood coagulation , 1978, Nature.
[41] C. Soria,et al. Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin. , 2001, Thrombosis research.
[42] S. Timmons,et al. Recognition site for the platelet receptor is present on the 15-residue carboxy-terminal fragment of the gamma chain of human fibrinogen and is not involved in the fibrin polymerization reaction. , 1983, Thrombosis research.
[43] S. Lord,et al. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr. , 1992, The Journal of clinical investigation.
[44] R. Doolittle,et al. Hybrid fibrin: proof of the intermolecular nature of - crosslinking units. , 1971, Biochemical and biophysical research communications.
[45] J. A. Méndez,et al. Twofold symmetry of human fibrinogen proved at the beta chain distal domains by monoclonal-immunoelectron microscopy and image analysis. , 1996, Biochemistry.
[46] C. Cierniewski,et al. Conservation of human fibrinogen conformation after cleavage of the B beta chain NH2 terminus. , 1985, The Journal of biological chemistry.
[47] S. Santoro,et al. Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins , 1987, Cell.
[48] J. Wall,et al. Evidence for a second type of fibril branch point in fibrin polymer networks, the trimolecular junction. , 1993, Blood.
[49] W. Mangel,et al. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin. , 1985, Biochemistry.
[50] K. Siebenlist,et al. Identification and Characterization of the Thrombin Binding Sites on Fibrin* , 1996, The Journal of Biological Chemistry.
[51] R. Clark,et al. Human Fibroblasts Bind Directly to Fibrinogen at RGD Sites through Integrin αvβ3 , 1997 .
[52] A. Sahni,et al. Fibrinogen and Fibrin Protect Fibroblast Growth Factor-2 from Proteolytic Degradation , 2000, Thrombosis and Haemostasis.
[53] E. Davie,et al. Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen , 1997 .
[54] J. Loscalzo,et al. Lipoprotein(a), fibrin binding, and plasminogen activation. , 1990, Arteriosclerosis.
[55] H. Scheraga,et al. The Fibrinogen-Fibrin Conversion1 , 1957 .
[56] T. Edgington,et al. Human Platelets Possess an Inducible and Saturable Receptor Specific for Fibrinogen , 1979, Thrombosis and Haemostasis.
[57] S. Lam,et al. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets. , 1987, The Journal of biological chemistry.
[58] Y. Matsuka,et al. Cross-Linking of Fibronectin to C-Terminal Fragments of the Fibrinogen α-Chain by Factor XIIIa , 1997, Journal of protein chemistry.
[59] C. Francis,et al. Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments. , 1993, The Journal of biological chemistry.
[60] G. Tsurupa,et al. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains. , 2001, Biochemistry.
[61] M. Gawinowicz,et al. Identification of the α Chain Lysine Donor Sites Involved in Factor XIIIa Fibrin Cross-linking* , 1996, The Journal of Biological Chemistry.
[62] H. Azuma,et al. Congenital Histidine-Rich Glycoprotein Deficiency , 1993, Thrombosis and Haemostasis.
[63] L. Hervio,et al. Multiple binding with identical linkage: a mechanism that explains the effect of lipoprotein(a) on fibrinolysis. , 1995, Biochemistry.
[64] D. Cheresh. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[65] B. M. Siegel,et al. An electron microscopic investigation of the polymerization of bovine fibrin monomer. , 1972, Journal of molecular biology.
[66] B. Gordon,et al. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[67] F. Rodeghiero,et al. High levels of histidine-rich glycoprotein and thrombotic diathesis. Report of two unrelated families. , 1993, Thrombosis research.
[68] L. Lorand,et al. Contact with the N Termini in the Central E Domain Enhances the Reactivities of the Distal D Domains of Fibrin to Factor XIIIa(*) , 1995, The Journal of Biological Chemistry.
[69] A. Chapel,et al. Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIbIIIa. , 1989, The Journal of biological chemistry.
[70] Jian-Zhong Zhang,et al. Identification of B @ Chain Domains Involved in Human Fibrinogen Assembly * , 2001 .
[71] A. Laudano,et al. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. , 1980, Biochemistry.
[72] N. Hasegawa,et al. Location of the binding site "b" for lateral polymerization of fibrin. , 1990, Thrombosis research.
[73] K. Siebenlist,et al. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. , 1996, Biochemistry.
[74] R. Willette,et al. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions. , 1998, Circulation research.
[75] R. Doolittle,et al. Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation. , 1983, Biochemistry.
[76] L. Medved,et al. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen. , 1996, Biochemistry.
[77] A. Sahni,et al. Potentiation of Endothelial Cell Proliferation by Fibrin(ogen)-bound Fibroblast Growth Factor-2* , 1999, The Journal of Biological Chemistry.
[78] K. Siebenlist,et al. The polymerization and thrombin-binding properties of des-(B beta 1-42)-fibrin. , 1990, The Journal of biological chemistry.
[79] J Martinez,et al. Fibrin II induces endothelial cell capillary tube formation , 1995, The Journal of cell biology.
[80] M. Hoylaerts,et al. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.
[81] S. Lord,et al. Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates. , 1996, Biochemistry.
[82] J. Hermans,et al. Cross-linked fibrinogen dimers demonstrate a feature of the molecular packing in fibrin fibers. , 1981, Science.
[83] N. Kirschbaum,et al. Characterization of the gamma chain platelet binding site on fibrinogen fragment D. , 1992, Blood.
[84] K. Siebenlist,et al. Evidence of intramolecular cross-linked A alpha.gamma chain heterodimers in plasma fibrinogen. , 1996, Biochemistry.
[85] S. Brennan,et al. The Amino Acid Sequence in Fibrin Responsible for High Affinity Thrombin Binding , 2001, Thrombosis and Haemostasis.
[86] H. Kanaide,et al. Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa). , 1976, The Journal of laboratory and clinical medicine.
[87] Hans,et al. The Sequence y-( 312-324 ) Is a Fibrin-Specific Epitope , 2003 .
[88] S. Madoiwa,et al. Fibroblasts Spread on Immobilized Fibrin Monomer by Mobilizing a β1-class Integrin, Together with a Vitronectin Receptor αvβ3 on Their Surface* , 1997, The Journal of Biological Chemistry.
[89] S. Sherry,et al. The preparation and properties of human fibrinogen of relatively high solubility. , 1966, Biochemistry.
[90] L. Leung. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. , 1986, The Journal of clinical investigation.
[91] K. Carlsson,et al. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. , 1994, Thrombosis research.
[92] J. F. Johnson,et al. An Antithrombin Reaction Related to Prothrombin Activation , 1953 .
[93] D. Powell,et al. Insulin-like Growth Factor-binding Protein-3 Binds Fibrinogen and Fibrin* , 1999, The Journal of Biological Chemistry.
[94] N. Kirschbaum,et al. Characterization of the y Chain Platelet Binding Site on Fibrinogen Fragment , 2022 .
[95] J. Soria,et al. Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). , 1987, Blood.
[96] Y. Sakata,et al. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. , 1982, The Journal of clinical investigation.
[97] D. Altieri,et al. The structural motif glycine 190-valine 202 of the fibrinogen gamma chain interacts with CD11b/CD18 integrin (alpha M beta 2, Mac-1) and promotes leukocyte adhesion. , 1993, The Journal of biological chemistry.
[98] J. Fontcuberta,et al. A New Case of Hereditary Histidine-rich Glycoprotein Deficiency with Familial Thrombophilia , 1996, Thrombosis and Haemostasis.
[99] D. Handley,et al. Fibrinogen New York 1: The structural, functional, and genetic defects and an hypothesis of the role of fibrin in the regulation of coagulation and fibrinolysis , 1986 .
[100] R. Doolittle,et al. Crystal structure of fragment double-D from human fibrin with two different bound ligands. , 1998, Biochemistry.
[101] J. Hainfeld,et al. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils. , 1995, Journal of structural biology.
[102] J. Weisel,et al. Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated alpha C fragments on polymerization. , 1993, The Journal of biological chemistry.
[103] A. Sahni,et al. Binding of Basic Fibroblast Growth Factor to Fibrinogen and Fibrin* , 1998, The Journal of Biological Chemistry.
[104] R. Doolittle,et al. Photoaffinity labeling of the primary fibrin polymerization site: isolation and characterization of a labeled cyanogen bromide fragment corresponding to gamma-chain residues 337-379. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[105] Y. Inada,et al. Distinctive role of histidine-16 of the B beta chain of fibrinogen in the end-to-end association of fibrin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[106] W. Bode,et al. A player of many parts: the spotlight falls on thrombin's structure. , 1993, Thrombosis research.
[107] J. Finlayson,et al. Biochemical and chromatographic studies of certain activities associated with human fibrinogen preparations. , 1963, The Journal of clinical investigation.
[108] M. Mosesson,et al. Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma'). , 1981, Biochemistry.
[109] J. Shainoff,et al. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking. , 1991, The Journal of biological chemistry.
[110] A. Shimizu. [Fibrinogen-fibrin conversion]. , 1990, Seikagaku. The Journal of Japanese Biochemical Society.
[111] E. Davie,et al. The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[112] M. Mosesson. FIBRINOGEN HETEROGENEITY * , 1983, Annals of the New York Academy of Sciences.
[113] E. Hewat,et al. Electron microscope structural study of modified fibrin and a related modified fibrinogen aggregate. , 1983, Journal of molecular biology.
[114] E. Davie,et al. The role of amino-terminal disulfide bonds in the structure and assembly of human fibrinogen. , 1993, Biochemical and biophysical research communications.
[115] J. Shainoff,et al. FIBRINOPEPTIDE B IN FIBRIN ASSEMBLY AND METABOLISM: PHYSIOLOGIC SIGNIFICANCE IN DELAYED RELEASE OF THE PEPTIDE * , 1983, Annals of the New York Academy of Sciences.
[116] J. Mcdonagh,et al. Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin , 1981, FEBS letters.
[117] W. Nieuwenhuizen,et al. The sequence Aα-(154 – 159) of fibrinogen is capable of accelerating the t‐PA catalysed activation of plasminogen , 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[118] T. Ugarova,et al. Localization of a fibrin polymerization site complementary to Gly‐His‐Arg sequence , 1993, FEBS letters.
[119] K. Siebenlist,et al. Factors affecting gamma-chain multimer formation in cross-linked fibrin. , 1992, Biochemistry.
[120] R. Doolittle,et al. - cross-linking sites in human and bovine fibrin. , 1971, Biochemistry.
[121] A. Laudano,et al. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[122] B. Blombäck,et al. Disulfide bridges in nh2 -terminal part of human fibrinogen. , 1976, Thrombosis research.
[123] N. Ohkura,et al. A novel degradation pathway of tissue factor pathway inhibitor: incorporation into fibrin clot and degradation by thrombin. , 1997, Blood.
[124] H. Scheraga,et al. Localization of the binding site on fibrin for the secondary binding site of thrombin. , 1988, Biochemistry.
[125] J. Koehn,et al. Characterization of fibrinogen New York 1. A dysfunctional fibrinogen with a deletion of B beta(9-72) corresponding exactly to exon 2 of the gene. , 1985, The Journal of biological chemistry.
[126] R. Albrecht,et al. Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids). , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[127] E. Plow,et al. Fibrinogen Is a Ligand for Integrin α5β1 on Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[128] W. Seegers,et al. NOTE ON THE ADSORPTION OF THROMBIN ON FIBRIN. , 1945, Science.
[129] C. Francis,et al. Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. , 1995, Blood.
[130] J. Soria,et al. Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta- fibrin) , 1987 .
[131] D. Rouy,et al. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin. , 1992, Biochimica et biophysica acta.
[132] C. Francis,et al. Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain. , 1993, Blood cells.
[133] M. Mosesson,et al. Dysfibrinogenemia and Thrombosis , 1999, Seminars in thrombosis and hemostasis.
[134] S. Brennan,et al. Fibrinogen Naples I (Bβ A68T) nonsubstrate thrombin-binding capacities , 2001 .
[135] C. Francis,et al. Heparin-binding domain of fibrin mediates its binding to endothelial cells. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[136] J. Ferry. The Mechanism of Polymerization of Fibrinogen. , 1952, Proceedings of the National Academy of Sciences of the United States of America.
[137] W. Nieuwenhuizen,et al. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites. , 2000, Biochemistry.
[138] K. Siebenlist,et al. Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[139] E. Levin. Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[140] M. Zabinski,et al. Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition. , 1988, Biochemistry.
[141] C. Redman,et al. Identification of B beta chain domains involved in human fibrinogen assembly. , 1992, The Journal of biological chemistry.
[142] E. Gabazza,et al. Characterization of the binding of factor Xa to fibrinogen/fibrin derivatives and localization of the factor Xa binding site on fibrinogen. , 1995, European journal of biochemistry.
[143] L. Bachmann,et al. Chromatography and electron microscopy of cross‐linked fibrin polymers—a new model describing the cross‐linking at the DD‐trans contact of the fibrin molecules , 1988, Biopolymers.
[144] M. Margaglione,et al. A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen). , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.